Uncovering How an Antifungal Substance Thickens the Yeast Cell Wall

October 23, 2026

Shedding light on a defense response triggered by an antifungal peptide derived from marine organisms

Fungal infections range from common conditions, such as athlete’s foot, to severe diseases that affect organs and the bloodstream. In particular, invasive fungal infections can be life-threatening and pose a significant global health challenge.

A research team led by Hiroshima University, the University of Tokyo, the RIKEN CSRS, and the University of Salamanca in Spain has elucidated the mechanism by which theonellamide A, an antifungal peptide found in marine sponges, causes abnormal thickening of the cell wall in fission yeast.
The researchers found that the thickening is primarily caused by excessive accumulation of 1,3-β-glucan, a major component of the fungal cell wall. They also revealed that this accumulation is associated with the prolonged retention of the enzyme responsible for glucan synthesis at the cell tips and sites of cell division. Furthermore, their findings suggest that Cdc42, a protein that regulates cell shape and growth direction, may be involved in this phenomenon.

Further elucidation of this mechanism is expected to contribute to the development of novel antifungal drugs with new modes of action.

 

Original article
iScience DOI: 10.1016/j.isci.2026.117645
K. Nakao, V. S. D. Carvalho, A. Suganaga, M. Osumi, M. Tokukura, H. Kakeya, A. Matsuyama, Y. Yashiroda, S. Matsunaga, J. C. G. Cortés, M. Yoshida, J. C. Ribas, S. Nishimura,
"Ectopic overproduction of cell wall glucan through membrane perturbation by an antifungal peptide theonellamide A in fission yeast".
Contact
Minoru Yoshida
Unit Leader
Drug Discovery Seeds Development Unit